Global Pharmacovigilance Market
According to Intent Market Research, the Pharmacovigilance Market is expected to grow from USD 7.8 Billion in 2024-e at a CAGR of 10.7% to touch USD 14.4 Billion by 2030. The Pharmacovigilance Market is dominated by key players such as Novartis International AG, Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., and Bristol-Myers Squibb Company.